BR112016013652A2 - Composição de imagem de cartilagem articular - Google Patents

Composição de imagem de cartilagem articular

Info

Publication number
BR112016013652A2
BR112016013652A2 BR112016013652A BR112016013652A BR112016013652A2 BR 112016013652 A2 BR112016013652 A2 BR 112016013652A2 BR 112016013652 A BR112016013652 A BR 112016013652A BR 112016013652 A BR112016013652 A BR 112016013652A BR 112016013652 A2 BR112016013652 A2 BR 112016013652A2
Authority
BR
Brazil
Prior art keywords
articular cartilage
image composition
site
imaging composition
composition
Prior art date
Application number
BR112016013652A
Other languages
English (en)
Other versions
BR112016013652B1 (pt
Inventor
Mizuno Shuichi
Kawaguchi Nobuaki
Tsuchiya Akihiro
Manome Yoshinobu
Original Assignee
Yasunori Fujiwara
Mercury Asset Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yasunori Fujiwara, Mercury Asset Man Co Ltd filed Critical Yasunori Fujiwara
Publication of BR112016013652A2 publication Critical patent/BR112016013652A2/pt
Publication of BR112016013652B1 publication Critical patent/BR112016013652B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A61K49/0034—Indocyanine green, i.e. ICG, cardiogreen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0056—Peptides, proteins, polyamino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0089—Particulate, powder, adsorbate, bead, sphere
    • A61K49/0091—Microparticle, microcapsule, microbubble, microsphere, microbead, i.e. having a size or diameter higher or equal to 1 micrometer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

COMPOSIÇÃO DE IMAGEM DE CARTILAGEM ARTICULAR. A presente invenção refere-se a uma composição de imagem de cartilagem articular que pode visualizar distinguivelmente de maneira clara um sítio normal e um sítio anormal, isto é, um sítio degenerativo, da cartilagem articular. A composição de imagem de cartilagem articular contém uma molécula positivamente carregada que é marcada com uma molécula marcadora.
BR112016013652-7A 2013-12-13 2014-12-08 Composição para visualizar um sítio degenerativo em cartilagem articular BR112016013652B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2013-257892 2013-12-13
JP2013257892 2013-12-13
PCT/JP2014/082441 WO2015087839A1 (ja) 2013-12-13 2014-12-08 関節軟骨イメージング組成物

Publications (2)

Publication Number Publication Date
BR112016013652A2 true BR112016013652A2 (pt) 2017-09-19
BR112016013652B1 BR112016013652B1 (pt) 2023-08-08

Family

ID=

Also Published As

Publication number Publication date
JP6220894B2 (ja) 2017-10-25
RU2667008C2 (ru) 2018-09-13
CN105873618A (zh) 2016-08-17
EP3081234A1 (en) 2016-10-19
CA2930840C (en) 2018-07-17
WO2015087839A1 (ja) 2015-06-18
ES2800524T3 (es) 2020-12-30
CA2930840A1 (en) 2015-06-18
CN105873618B (zh) 2019-07-26
KR20160094943A (ko) 2016-08-10
EP3081234A4 (en) 2017-06-14
EP3081234B1 (en) 2020-04-08
US20170157271A1 (en) 2017-06-08
JPWO2015087839A1 (ja) 2017-03-16
SG11201604227XA (en) 2016-07-28
AU2014362497A1 (en) 2016-06-16
US10143762B2 (en) 2018-12-04
MX2016006991A (es) 2017-02-02
KR101860117B1 (ko) 2018-05-21
AU2014362497B2 (en) 2017-03-02

Similar Documents

Publication Publication Date Title
ECSP16061758A (es) Moduladores de tetrahidropiridopirazinas de gpr6
BR112015022545A2 (pt) compostos de pirazolo e os usos disso
BR112013007362A2 (pt) composição farmacêutica
GT201400195A (es) Compuestos de heterociclilo como inhibidores de mek
BR112016013299A2 (pt) Composto
BR112016024494A2 (pt) análogos de peptídeo com sonda(s) de aminoácidos ramificados
BR112014029933A2 (pt) aparelho para teste de eletrodo
BR112014006845A2 (pt) construção de lista de imagens de referência para codificação de vídeo
BR112016011755A2 (pt) derivado de ureia ou sal farmacologicamente aceitável do mesmo
BR112015009989A2 (pt) estabilizante para a hialuronidase e formulação líquida que compreende hialuronidase
BR112016013194A2 (pt) Composições de higiene oral compreendendo carbonato de cálcio e sílica
CL2015000976A1 (es) Compuestos de 2-fenil-5-heterociclil-tetrahidro-2h-piran-3-amina para uso en el tratamiento de diabetes y sus trastornos asociados.
UY34111A (es) Nuevos co-cristales de agomelatina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
CO6650346A2 (es) Composiciones de tetraciclina
CL2016000568A1 (es) Compuestos derivados de 2h-indazol-2-il-n-hidroxi-2-metilsulfonil-2-metil-butanamida sustituidos o sus sales; sus composiciones farmacéuticas que los contiene y su uso para la prevención y/o tratamiento de infecciones bacterianas gram-negativas.
BR112015008117A2 (pt) benzamidas
BR112018009609A2 (pt) composições dentifrícias com absorção melhorada de fluoreto
BR112015024332A2 (pt) sonda fluorescente para estanho
BR112013026383A2 (pt) composição da gestão de temperatura
AU2018253594A1 (en) Dihydroxyphenyl neurotransmitter compounds, compositions and methods
UY33496A (es) Derivados heterociclicos fusionados como moduladores s1p
BR112013033051A2 (pt) roda dentada com endentação inclinada e segmento para uma roda dentada
BR112015009301A2 (pt) biocontrole de nematoides
BR112013002204A2 (pt) placa de amostra
BR112015031293A2 (pt) politiol, composição para materiais ópticos, material óptico, e, lente

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 08/12/2014, OBSERVADAS AS CONDICOES LEGAIS